SPDEF and prostate carcinoma: Since reduced SPDEF expression/activity is a key driver of metastasis in prostate cancer, we tested our hypothesis that the interplay between GADD45α and CDK11p58 elicits its effects on prostate cancer migration and invasion through modulation of SPDEF expression or activity.